Daiwa Securities Group
NAUT icon

Daiwa Securities Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Daiwa Securities Group’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-362
Closed -$1K – 1314
2024
Q3 		$1K Hold
362
– – ﹤0.01% 1255
2024
Q2 		$1K Hold
362
– – ﹤0.01% 1296
2024
Q1 		$1K Hold
362
– – ﹤0.01% 1300
2023
Q4 		$1K Hold
362
– – ﹤0.01% 1303
2023
Q3 		$1K Hold
362
– – ﹤0.01% 1265
2023
Q2 		$1K Hold
362
– – ﹤0.01% 1287
2023
Q1 		$1K Hold
362
– – ﹤0.01% 1266
2022
Q4 		$1K Hold
362
– – ﹤0.01% 1280
2022
Q3 		$1K Hold
362
– – ﹤0.01% 1302
2022
Q2 		$1K Hold
362
– – ﹤0.01% 1305
2022
Q1 		$2K Hold
362
– – ﹤0.01% 1263
2021
Q4 		$2K Buy
+362
New +$1.94K ﹤0.01% 1289

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Daiwa Securities Group's NAUT Position: Q4 2024 in Review

Daiwa Securities Group sold out of Nautilus Biotechnolgy (NAUT) in Q4 2024, closing a stake of 362 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in NAUT in Q4 2021 and held it in 12 quarters. The position peaked at $2K in Q1 2022. 88 funds tracked by Wall St. Rank hold NAUT as of Q4 2024.

  • Daiwa Securities Group reported no remaining Nautilus Biotechnolgy position as of Q4 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 362 Nautilus Biotechnolgy shares in Q4 2024, an estimated $1K.
  • Daiwa Securities Group first reported a position in Nautilus Biotechnolgy in Q4 2021 and held it in 12 quarters.
  • Daiwa Securities Group's Nautilus Biotechnolgy position peaked at $2K in Q1 2022.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2024.

Based on Daiwa Securities Group's 13F filing for Q4 2024, filed 7 Feb 2025.